b 576
Pill imprint b 576 has been identified as Granisetron hydrochloride 1 mg.
Granisetron is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative; nausea/vomiting, radiation induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy.
Granisetron 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Granisetron hydrochloride Images
- Imprint:
-
b
576 - Strength:
- 1 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
Advertisement
More Granisetron Hydrochloride resources
- Granisetron (Wolters Kluwer)
- Granisetron Solution (Wolters Kluwer)
- Granisetron Tablets (Wolters Kluwer)
- granisetron (Cerner Multum)
- granisetron transdermal (Cerner Multum)
- granisetron Oral, Intravenous (Micromedex) - Includes Dosage Information
- granisetron Transdermal (Micromedex) - Includes Dosage Information
- Granisetron Hydrochloride (AHFS DI)
- Granisetron (FDA)
- Granisetron Injection (FDA)
- Kytril Injection (FDA)
- Granisetron Hydrochloride (Wolters Kluwer)
Search Again
